BIOMAT Database Logo BIOMAT Database Logo

[Diagnosis and treatment of risk factors in chronic ischemic heart disease]. 1974

A Neugebauer, and H Trenckmann, and H J Duck, and H J Fleischmann, and J Schauer

UI MeSH Term Description Entries
D006949 Hyperlipidemias Conditions with excess LIPIDS in the blood. Hyperlipemia,Hyperlipidemia,Lipemia,Lipidemia,Hyperlipemias,Lipemias,Lipidemias
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009539 Nicotinic Acids 2-, 3-, or 4-Pyridinecarboxylic acids. Pyridine derivatives substituted with a carboxy group at the 2-, 3-, or 4-position. The 3-carboxy derivative (NIACIN) is active as a vitamin. Acids, Nicotinic
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D002792 Cholestyramine Resin A strongly basic anion exchange resin whose main constituent is polystyrene trimethylbenzylammonium Cl(-) anion. Cholestyramine,Colestyramine,Colestyramin,Cuemid,MK-135,Quantalan,Questran,Cholestyramine Resins,Cholestyramines,Colestyramines,Colestyramins,Cuemids,MK 135,MK135,Quantalans,Questrans,Resin, Cholestyramine,Resins, Cholestyramine
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D002994 Clofibrate A fibric acid derivative used in the treatment of HYPERLIPOPROTEINEMIA TYPE III and severe HYPERTRIGLYCERIDEMIA. (From Martindale, The Extra Pharmacopoeia, 30th ed, p986) Athromidin,Atromid,Atromid S,Clofibric Acid, Ethyl Ester,Ethyl Chlorophenoxyisobutyrate,Miscleron,Miskleron,Chlorophenoxyisobutyrate, Ethyl
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary

Related Publications

A Neugebauer, and H Trenckmann, and H J Duck, and H J Fleischmann, and J Schauer
Outcome and risk factors of ischemic heart disease in chronic uremia.
May 1996, Kidney international,
A Neugebauer, and H Trenckmann, and H J Duck, and H J Fleischmann, and J Schauer
[Diagnosis and treatment of chronic forms of ischemic heart disease].
June 1977, Kardiologiia,
A Neugebauer, and H Trenckmann, and H J Duck, and H J Fleischmann, and J Schauer
Ischemic heart disease risk factors.
January 1980, North Carolina dental journal,
A Neugebauer, and H Trenckmann, and H J Duck, and H J Fleischmann, and J Schauer
[Ischemic heart disease--risk factors].
January 1988, Vutreshni bolesti,
A Neugebauer, and H Trenckmann, and H J Duck, and H J Fleischmann, and J Schauer
[Risk factors in ischemic heart disease].
January 1972, Vnitrni lekarstvi,
A Neugebauer, and H Trenckmann, and H J Duck, and H J Fleischmann, and J Schauer
[Risk factors in ischemic heart disease].
January 1981, Zeitschrift fur Alternsforschung,
A Neugebauer, and H Trenckmann, and H J Duck, and H J Fleischmann, and J Schauer
Risk factors in ischemic heart disease.
March 1963, American journal of public health and the nation's health,
A Neugebauer, and H Trenckmann, and H J Duck, and H J Fleischmann, and J Schauer
Risk Factors for Ischemic Heart Disease.
January 2019, Reviews on recent clinical trials,
A Neugebauer, and H Trenckmann, and H J Duck, and H J Fleischmann, and J Schauer
[Ischemic heart disease risk factors in students].
January 1986, Terapevticheskii arkhiv,
A Neugebauer, and H Trenckmann, and H J Duck, and H J Fleischmann, and J Schauer
[Risk factors in ischemic heart disease patients].
January 1978, Vutreshni bolesti,
Copied contents to your clipboard!